Literature DB >> 7519048

MDM2 gene amplification correlates with ring chromosome in soft tissue tumors.

M Nilbert1, A Rydholm, H Willén, F Mitelman, N Mandahl.   

Abstract

The human homolog of the murine double minute type 2 gene (MDM2) has been cloned and mapped to 12q13-14. The gene presumably functions as a cellular regulator and mediator of TP53 function. Amplification of the MDM2 gene has recently been observed in soft tissue sarcoma and in osteosarcoma. We studied MDM2 amplification in a series of 94 mesenchymal tumors and found 3-20-fold amplification in 20 tumors: in 10 of 49 malignant fibrous histiocytomas (MFH), in 1 of 2 pleomorphic liposarcomas, in 6 of 7 atypical lipomas, and in 3 of 12 typical lipomas. Normal hybridization patterns were detected in all 16 myxoid liposarcomas, in all 3 leiomyosarcomas, and in all 5 leiomyomas studied. The MDM2 amplification correlated with the presence of marker ring chromosomes; of the 10 MFH with MDM2 amplification, 5 had ring chromosomes, compared to 4 of 39 without MDM2 amplification, and all 9 liposomas with MDM2 amplification had ring chromosomes, in 5 of the tumors as the sole karyotypic anomaly. The correlation between ring chromosomes and MDM2 gene amplification indicates that the marker rings of MFH and of atypical lipoma often harbor genetic material derived from chromosome 12.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519048     DOI: 10.1002/gcc.2870090406

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  13 in total

1.  Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker.

Authors:  M L Larramendy; M Tarkkanen; C Blomqvist; M Virolainen; T Wiklund; S Asko-Seljavaara; I Elomaa; S Knuutila
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  MDM2/p53 protein expression in the development of colorectal adenocarcinoma.

Authors:  G Abdel-Fattah; B Yoffe; B Krishnan; V Khaoustov; K Itani
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

Review 3.  Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia - a review.

Authors:  Erich Gebhart
Journal:  Clin Transl Oncol       Date:  2005-12       Impact factor: 3.405

Review 4.  Patterns of oncogene activation in human neuroblastoma cells.

Authors:  R Corvi; L Savelyeva; M Schwab
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

Review 5.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Authors:  S Knuutila; A M Björkqvist; K Autio; M Tarkkanen; M Wolf; O Monni; J Szymanska; M L Larramendy; J Tapper; H Pere; W El-Rifai; S Hemmer; V M Wasenius; V Vidgren; Y Zhu
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

6.  PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms.

Authors:  D Gisselsson; M K Hibbard; P Dal Cin; R Sciot; B L Hsi; H P Kozakewich; J A Fletcher
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

7.  Liposarcoma in children and young adults: a multi-institutional experience.

Authors:  Winston W Huh; Carrie Yuen; Mark Munsell; Andrea Hayes-Jordan; Alexander J Lazar; Shreyaskumar Patel; Wei-Lien Wang; Nadia Barahmani; M Fatih Okcu; John Hicks; Larisa Debelenko; Sheri L Spunt
Journal:  Pediatr Blood Cancer       Date:  2011-03-10       Impact factor: 3.167

Review 8.  The MDM2 gene amplification database.

Authors:  J Momand; D Jung; S Wilczynski; J Niland
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

9.  Prognostic factors and expression of MDM2 in patients with primary extremity liposarcoma.

Authors:  Rosalvo Zósimo Bispo Júnior; Olavo Pires de Camargo; Cláudia Regina G C M de Oliveira; Renée Zon Filippi; André Mathias Baptista; Marcelo Tadeu Caiero
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

10.  Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas.

Authors:  A Forus; J M Berner; L A Meza-Zepeda; G Saeter; D Mischke; O Fodstad; O Myklebost
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.